These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26131981)

  • 1. The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.
    Gillespie DO; Allen K; Guzman-Castillo M; Bandosz P; Moreira P; McGill R; Anwar E; Lloyd-Williams F; Bromley H; Diggle PJ; Capewell S; O'Flaherty M
    PLoS One; 2015; 10(7):e0127927. PubMed ID: 26131981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
    Collins M; Mason H; O'Flaherty M; Guzman-Castillo M; Critchley J; Capewell S
    Value Health; 2014 Jul; 17(5):517-24. PubMed ID: 25128044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study.
    Pearson-Stuttard J; Critchley J; Capewell S; O'Flaherty M
    PLoS One; 2015; 10(8):e0132524. PubMed ID: 26247848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.
    Mason H; Shoaibi A; Ghandour R; O'Flaherty M; Capewell S; Khatib R; Jabr S; Unal B; Sözmen K; Arfa C; Aissi W; Ben Romdhane H; Fouad F; Al-Ali R; Husseini A;
    PLoS One; 2014; 9(1):e84445. PubMed ID: 24409297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.
    Allen K; Pearson-Stuttard J; Hooton W; Diggle P; Capewell S; O'Flaherty M
    BMJ; 2015 Sep; 351():h4583. PubMed ID: 26374614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?
    Hyseni L; Elliot-Green A; Lloyd-Williams F; Kypridemos C; O'Flaherty M; McGill R; Orton L; Bromley H; Cappuccio FP; Capewell S
    PLoS One; 2017; 12(5):e0177535. PubMed ID: 28542317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future trends and inequalities in premature coronary deaths in England: Modelling study.
    Allen K; Gillespie DO; Guzman-Castillo M; Diggle PJ; Capewell S; O'Flaherty M
    Int J Cardiol; 2016 Jan; 203():290-7. PubMed ID: 26520277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of simulation models in health economic evaluation studies of dietary salt-reduction policies for cardiovascular disease prevention].
    Kato H; Ikeda N; Sugiyama T; Nomura M; Yoshita K; Nishi N
    Nihon Koshu Eisei Zasshi; 2021 Sep; 68(9):631-643. PubMed ID: 34261839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of maximising the UK's tobacco control score on inequalities in smoking prevalence and premature coronary heart disease mortality: a modelling study.
    Allen K; Kypridemos C; Hyseni L; Gilmore AB; Diggle P; Whitehead M; Capewell S; O'Flaherty M
    BMC Public Health; 2016 Apr; 16():292. PubMed ID: 27036296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calorie labelling in the out-of-home food sector on adult obesity prevalence, cardiovascular mortality, and social inequalities in England: a modelling study.
    Colombet Z; Robinson E; Kypridemos C; Jones A; O'Flaherty M
    Lancet Public Health; 2024 Mar; 9(3):e178-e185. PubMed ID: 38429017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study.
    Kypridemos C; Guzman-Castillo M; Hyseni L; Hickey GL; Bandosz P; Buchan I; Capewell S; O'Flaherty M
    BMJ Open; 2017 Jan; 7(1):e013791. PubMed ID: 28119387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying benefits of the Danish transfat ban for coronary heart disease mortality 1991-2007: Socioeconomic analysis using the IMPACTsec model.
    Bjoernsbo KS; Joensen AM; Joergensen T; Lundbye-Christensen S; Bysted A; Christensen T; Fagt S; Capewell S; O'Flaherty M
    PLoS One; 2022; 17(8):e0272744. PubMed ID: 35976852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study.
    Bajekal M; Scholes S; Love H; Hawkins N; O'Flaherty M; Raine R; Capewell S
    PLoS Med; 2012; 9(6):e1001237. PubMed ID: 22719232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study.
    Guzman-Castillo M; Ahmed R; Hawkins N; Scholes S; Wilkinson E; Lucy J; Capewell S; O'Flaherty M
    BMJ Open; 2015 Jan; 5(1):e006070. PubMed ID: 25613952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.
    Pearson-Stuttard J; Hooton W; Critchley J; Capewell S; Collins M; Mason H; Guzman-Castillo M; O'Flaherty M
    J Public Health (Oxf); 2017 Sep; 39(3):574-582. PubMed ID: 27613767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: an analytical study.
    Bajekal M; Scholes S; O'Flaherty M; Raine R; Norman P; Capewell S
    PLoS One; 2013; 8(3):e59608. PubMed ID: 23527228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying policy options for reducing future coronary heart disease mortality in England: a modelling study.
    Scholes S; Bajekal M; Norman P; O'Flaherty M; Hawkins N; Kivimäki M; Capewell S; Raine R
    PLoS One; 2013; 8(7):e69935. PubMed ID: 23936122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the impact of the Public Health Responsibility Deal on salt intake, cardiovascular disease and gastric cancer burdens: interrupted time series and microsimulation study.
    Laverty AA; Kypridemos C; Seferidi P; Vamos EP; Pearson-Stuttard J; Collins B; Capewell S; Mwatsama M; Cairney P; Fleming K; O'Flaherty M; Millett C
    J Epidemiol Community Health; 2019 Sep; 73(9):881-887. PubMed ID: 31320459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Brexit on the effectiveness of the UK soft drinks industry levy upon CHD in England: a modelling study.
    Seferidi P; Laverty AA; Pearson-Stuttard J; Guzman-Castillo M; Collins B; Capewell S; O'Flaherty M; Millett C
    Public Health Nutr; 2018 Dec; 21(18):3431-3439. PubMed ID: 30296966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing salt in food; setting product-specific criteria aiming at a salt intake of 5 g per day.
    Dötsch-Klerk M; Goossens WP; Meijer GW; van het Hof KH
    Eur J Clin Nutr; 2015 Jul; 69(7):799-804. PubMed ID: 25690867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.